FIDURA Private Equity Funds: Successful sale of portfolio company m2p-labs GmbH to Beckman Coulter Life Sciences
FIDURA Private Equity Funds, headquartered in Gruenwald near Munich, Germany and co-investors including the High-Tech Gr…
FIDURA Private Equity Funds, headquartered in Gruenwald near Munich, Germany and co-investors including the High-Tech Gr…
The European Patent Office has granted a patent to m2p-labs of Baesweiler, Germany, for an innovative microbioreactor de…
Founded in 2005, m2p-labs GmbH successfully closed its financing round with FIDURA Private Equity Fonds as a new lead in…
m2p-labs wins the competition "Bioeconomy's Next Business Model" at the BIOTECHNICA fair. For the first time BIOTECHNICA…
m2p-labs launches a next generation microbioreactor technology, the BioLector® Pro, at the m2p-labs booth G20, Hall 9, a…
Once again, m2p-labs demonstrates its innovation power and launches the RoboLector. The RoboLector is a unique, automate…